Skip to main content
Fig. 1 | Clinical Proteomics

Fig. 1

From: Precision medicine: from pharmacogenomics to pharmacoproteomics

Fig. 1

Integration of ‘omics’ technologies for precision medicine. The realization of precision medicine via the discovery and development of biomarkers for disease detection, therapy, and prediction of drug response will involve the integration of technologies which analyze control and disease-relevant samples at the genomic, transcriptomic, and proteomic levels. This schematic details some examples of such technologies. NGS next-generation sequencing

Back to article page